MUCIN2 (MUC2) glycopeptides are crucial components of the MUC2 mucin, predominantly located in the gastrointestinal tract where they play a key role in maintaining mucosal barrier function. Medical research is investigating their potential as diagnostic biomarkers for gastrointestinal cancers due to observed alterations in MUC2 glycosylation patterns. In addition, researchers are exploring the use of MUC2 as a biomarker for various cancers, including breast, ovarian, prostate, and pancreatic cancers. Furthermore, there is ongoing research into developing MUC2 glycopeptide-based vaccines to leverage their immunogenic properties for creating targeted therapies against gastrointestinal tumors. This research underscores the significance of MUC2 in both cancer detection and the advancement of therapeutic strategies.
